Breaking News
Get 50% Off 0
Top 10 Stocks Best Positioned to Break Out This Earnings Season
See the List
Close

Cellebrite DI (CLBT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Cellebrite's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
14.580 -0.130    -0.88%
20:59:59 - Closed. Currency in USD
After Hours
14.570
-0.010
-0.069%
23:28:05 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,562,113
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 14.380 - 14.784
Cellebrite 14.580 -0.130 -0.88%

Cellebrite DI Company Profile

 
Get an in-depth profile of Cellebrite DI, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustrySoftware & IT Services
SectorTechnology
Employees

1167

Equity Type

ORD

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company’s DI suite of solutions allows users to access, collect, review, extract, decode, decrypt, analyze, share, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company’s digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Endpoint Mobile Now; and professional services, such as training and certification services, and advanced services. It serves federal and state and local agencies. The company was founded in 1999 and is headquartered in Petah Tikva, Israel.

Contact Information

Address 94 Shlomo Shmelzer Road P.O.B 3925
Petah Tikva, 4970602
Israel
Phone 972 73 394 8000
Fax 972 3 924 7104

Top Executives

Name Age Since Title
Alexi A. Wellman 51 2020 Independent Director
Darren Thompson 58 2020 Independent Director
James H. Greene 70 2020 Chairman of the Board of Directors
Lee Kirkpatrick 60 2021 Independent Director
Adam H. Clammer 51 2020 CEO, President & Director
Nadine Baudot-Trajtenberg 69 2021 Independent External Director
Dafna Gruber 60 2021 Independent External Director
Ryusuke Utsumi 60 2020 Independent Director
Michael D. Capellas 70 - Lead Independent Director
Koby Huberman - - Advisory Board Member
Barbara Grewe - 2024 Independent Director
Yonatan Domnitz 44 2020 Independent Director
Mark J. Ferrer 65 2024 Independent Director
Elly Keinan 59 2020 Independent Director
Ken Tovo - 2024 Independent Director
Brandon B. Van Buren 42 2023 Independent Director
Barry C. West - 2024 Independent Director
Adam H. Clammer 55 2021 Independent Chairman
Thomas E. Hogan 66 2023 CEO & Director
Troy K. Richardson 62 2024 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CLBT Comments

Write your thoughts about Cellebrite DI
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email